CRF07-BC strain dominates the HIV-1 epidemic in injection drug users in liangshan prefecture of Sichuan, China

AIDS Research and Human Retroviruses

Volumn 31, Issue 5, 2015, Pages 479-487

  Li, Lin ^a   Wei, Daying ^b   Hsu, Wan Ling ^c   Li, Tianyi ^a   Gui, Tao ^a   Wood, Charles ^c   Liu, Yongjian ^a   Li, Hanping ^a   Bao, Zuoyi ^a   Liu, Siyang ^a   Wang, Xiaolin ^a   Li, Jingyun ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Liangshan Center for Disease Control and Prevention   (China)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; GAG PROTEIN; NELFINAVIR; NEVIRAPINE; POL PROTEIN; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHINA; CONTROLLED STUDY; DEVELOPMENT; DRUG USE; EPIDEMIC; ETHNIC GROUP; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; MIDDLE AGED; MOLECULAR CLOCK; PHYLOGENETIC TREE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS MUTATION; VIRUS STRAIN; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; DISEASE TRANSMISSION; DNA SEQUENCE; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; PRESCHOOL CHILD; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHINA; CLUSTER ANALYSIS; DISEASE TRANSMISSION, INFECTIOUS; DRUG USERS; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84928947189     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0120     Document Type: Article

References (50)

1. Buonaguro L, Tornesello ML, and Buonaguro FM: Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications. J Virol 2007;81(19):10209-10219.
2. Butler IF, Pandrea I, Marx PA, and Apetrei C: HIV genetic diversity: Biological and public health consequences. Curr HIV Res 2007;5(1):23-45.
3. McCutchan FE: Global epidemiology of HIV. J Med Virol 2006;78(Suppl 1):S7-S12.
4. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal. Science 2000;288(5463):55-56.
5. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006;20(16):W13-23.
6. Peeters M and Sharp PM: Genetic diversity of HIV-1: The moving target. AIDS 2000;14(Suppl 3):S129-140.
7. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011;25(5):679-689.
8. Piyasirisilp S, McCutchan FE, Carr JK, et al.: A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000; 74(23):11286-11295.
9. Su L, Graf M, Zhang Y, et al.: Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol 2000;74(23):11367-11376.
10. Yu XF, Chen J, Shao Y, et al.: Two subtypes of HIV-1 among injection-drug users in southern China. Lancet 1998;351(9111):1250.
11. Yu ES, Xie Q, Zhang K, et al.: HIV infection and AIDS in China, 1985 through 1994.AmJ Public 1996;86(8):1116-1122.
12. Lin YT, Lan YC, Chen YJ, et al.: Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07-BC strains from injection drug users in Taiwan. J Infect Dis 2007;195(9):1283-1293.
13. He X, Xing H, Ruan Y, et al.: A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One 2012;7(10):e47289.
14. Li L, Han N, Lu J, et al.: Genetic characterization and transmitted drug resistance of the HIV type 1 epidemic in men who have sex with men in Beijing, China. AIDS Res Hum Retroviruses 2013;29(3):633-637.
15. Li L, Sun G, Li T, et al.: Multiple introductions of HIV into men who have sex with men were found in Zhengzhou City, China. AIDS Res Hum Retroviruses 2012;28(9): 1147-1151.
16. Tee KK, Pybus OG, Li XJ, et al.: Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08-BC and 07-BC in Asia. J Virol 2008;82(18):9206-9215.
17. Liu J and Zhang C: Phylogeographic analyses reveal a crucial role of Xinjiang in HIV-1 CRF07-BC and HCV 3a transmissions in Asia. PLoS One 2011;6(8):e23347.
18. Meng Z, Xin R, Zhong P, et al.: A new migration map of HIV-1 CRF07-BC in China: Analysis of sequences from 12 provinces over a decade. PLoS One 2012;7(12): e52373.
19. Ruan Y, Chen K, Hong K, et al.: Community-based survey of HIV transmission modes among intravenous drug users in Sichuan, China. Sex Transm Dis 2004;31(10): 623-627.
20. Ruan Y, Qin G, Liu S, et al.: HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. J Acquir Immune Defic Syndr 2005;39(4):459-463.
21. Sichuan Province CDC: Surveillance report of HIV/AIDS in Sichuan Province 2007. 2008.
22. Liangshan Prefecture CDC: Surveillance report of HIV/AIDS in Liangshan Yi Autonomous Prefecture 1990-2007. 2008.
23. Lu L, Jia MH, Zhang XB, et al.: [Analysis for epidemic trend of acquired immunodeficiency syndrome in Yunnan Province of China]. Zhonghua Yu Fang Yi Xue Za Zhi 2004;38(5):309-312.
24. Xiao Y, Jiang Y, Feng J, et al.: Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol 2007;14(10):1384-1386.
25. Wu Z: Recent trends of injecting drug use and related HIV infection in China. Global Research Network Meeting on HIV Prevention in Drug-Using Populations: Inauguration Meeting Report. National Institute on Drug Abuse, Geneva, Switzerland, 1999.
26. Li L, Lu X, Li H, et al.: High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China. Infect Genet Evol 2011;11(6):1487-1492.
27. Li L, Liang S, Chen L, et al.: Genetic characterization of 13 subtype CRF01-AE near full-length genomes in Guangxi, China. AIDS Res Hum Retroviruses 2010;26(6):699-704.
28. Tamura K, Peterson D, Peterson N, et al.: MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28(10):2731-2739.
29. Guindon S and Gascuel O: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003;52(5):696-704.
30. Posada D: jModelTest: Phylogenetic model averaging. Mol Biol Evol 2008;25(7):1253-1256.
31. Alizon S and Fraser C: Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology 2013;10:49.
32. Drummond AJ and Rambaut A: BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 2007;7:214.
33. Bennett DE, Camacho RJ, Otelea D, et al.: Drug resistance mutations for surveillance of transmitted HIV-1 drugresistance: 2009 update. PLoS One 2009;4(3):e4724.
34. Shafer RW, Rhee SY, Pillay D, et al.: HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 2007;21(2):215-223.
35. China Ministry of Health: UNAIDS and WHO. 2007 update on the HIV/AIDS epidemic and response in China. China Ministry of Health, Beijing, 2007.
36. Yang C, Latkin C, Luan R, et al.: HIV, syphilis, hepatitis C and risk behaviours among commercial sex male clients in Sichuan province, China. Sex Transm Infect 2010;86(7): 559-564.
37. Adler MW: ABC of Aids: Development of the epidemic. BMJ 2001;322(7296):1226-1229.
38. Shang H, Xu J, Han X, et al.: HIV prevention: Bring safe sex to China. Nature 2012;485(7400):576-577.
39. Hertog S: Heterosexual behavior patterns and the spread of HIV/AIDS: The interacting effects of rate of partner change and sexual mixing. Sex Transm Dis 2007;34(10):820-828.
40. Lau JT, Feng T, Lin X, et al.: Needle sharing and sex-related risk behaviours among drug users in Shenzhen, a city in Guangdong, southernChina.AIDS Care 2005;17(2):166-181.
41. Lau JT, Zhang L, Zhang Y, et al.: Changes in the prevalence of HIV-related behaviors and perceptions among 1832 injecting drug users in Sichuan, China. Sex Transm Dis 2008;35(4):325-335.
42. Choi SY, Cheung YW, and Chen K: Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China. Soc Sci Med 2006;62(7):1672-1684.
43. Ruan S, Yang H, Zhu Y, et al.: HIV prevalence and correlates of unprotected anal intercourse among men who have sex with men, Jinan, China. AIDS Behav 2008;12(3):469-475.
44. Zhang D, Bi P, Lv F, et al.: Changes in HIV prevalence and sexual behavior among men who have sex with men in a northern Chinese city: 2002-2006. J Infect 2007;55(5): 456-463.
45. Zhang C, Yang R, Xia X, et al.: High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. J Acquir Immune Defic Syndr 2002;29(2):191-196.
46. Mi G, Wu Z, Zhang B, and Zhang H: Survey on HIV/AIDS-related high risk behaviors among male sex workers in two cities in China. AIDS 2007;21(Suppl 8):S67-72.
47. MAP: AIDS in Asia: Face the fact. A comprehensive analysis of the AIDS epidemic in Asia. In Monitoring the AIDS Pandemic (MAP). 2004.
48. UNAIDS: AIDS epidemic update. UNAIDS and WHO, Geneva, 2006.
49. Wang Z, Liang Y, and Xin T: Investigation on curative effect and drug resistance of HIV/AIDS patients receiving HAART. J Med Forum 2005;26:1-3.
50. Leng X, Liang S, Ma Y, et al.: HIV virological failure and drug resistance among injecting drug users receiving firstline ART in China. BMJ Open 2014;4(10):e005886.